文献速递技术与安全泌尿生殖PETCT

前列腺特异性膜抗原(PSMA)亲和性非前列腺良恶性疾病的图谱综述

Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review.
PubMed 文献 · Clin Radiol · 2024-05-24

本文为图谱综述,阐述PSMA PET-CT在前列腺癌分期与生化复发评估中应用广泛,但PSMA表达并非前列腺特异,多种非前列腺良恶性疾病亦可出现PSMA摄取,增加PET-CT判读与临床管理复杂度;综述系统展示这些疾病并强调其他影像模态的补充作用。

要点

  • PSMA PET-CT用于前列腺癌初始分期和生化复发评估,诊断准确性高于传统影像和既往PET放射性药物。
  • PSMA表达并非前列腺特异,非前列腺良恶性病变也可表现PSMA摄取,判读时需纳入鉴别。
  • 图谱综述系统展示非前列腺PSMA亲和性病变,并强调其他影像模态的补充价值。

核心结论

  • PSMA PET-CT应用日益增多,已发现多种非前列腺良恶性疾病出现PSMA摄取,增加PET-CT判读和后续临床管理的复杂性。

研究设计与样本

  • 图谱综述,系统展示PSMA PET-CT上可显示的非前列腺PSMA亲和性良恶性疾病谱,并强调其他影像模态的补充作用。

关键影像表现/征象

  • PSMA是一种跨膜糖蛋白,在前列腺癌中高表达,其细胞外域是PSMA PET放射性药物的靶点。
  • PSMA摄取并非局限于前列腺来源病变,多种非前列腺良恶性疾病在PSMA PET-CT上亦可表现为摄取。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Prostate specific membrane antigen (PSMA) positron emission tomography-computed tomography (PET-CT) is revolutionising the management of prostate cancer (PC) in primary staging and assessment of biochemical recurrence (BCR) through its higher diagnostic accuracy compared to both conventional imaging and previously available PET radiopharmaceuticals. PSMA is a transmembrane glycoprotein, highly expressed in prostate cancer, with its extracellular domain the target for PSMA PET radiopharmaceuticals. However, PSMA expression is not prostate specific and resultant PSMA uptake on PET-CT is not restricted to pathologies arising from the prostate gland. The increasing use of PSMA PET-CT has revealed PSMA uptake in a variety of non-prostatic benign and malignant diseases, which adds complexity to PET-CT interpretation and subsequent clinical management. This pictorial review will provide a thorough knowledge and understanding of the comprehensive range of PSMA avid non-prostatic benign and malignant diseases demonstrable on PSMA PET-CT, whilst highlighting the complimentary nature of other imaging modalities.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Srinivasan R, Cook GJR, Patel N, et al. Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review. Clin Radiol. 2024. PMID: 38926052. doi:10.1016/j.crad.2024.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。